CPT1A and depressive symptom measurement: Ultimately, this finding could add to the emerging evidence that targeting cellular metabolism offers a potential therapeutic pathway in depression: A study in an animal model of depression (Morkholt et al., 2017) has provided evidence that chronic stress increases CPT1a expression both in the CNS and in the immune system and that treatment with etomoxir decreases depression-like behavior in rats.